Carmell (CTCX) Competitors $0.62 -0.14 (-18.42%) As of 10/10/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CTCX vs. ICCM, DXR, QTI, MDAI, TELA, BDMD, CTSO, SURG, NEPH, and PYPDShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include IceCure Medical (ICCM), Daxor (DXR), QT Imaging (QTI), Spectral AI (MDAI), TELA Bio (TELA), Baird Medical Investment (BDMD), Cytosorbents (CTSO), SurgePays (SURG), Nephros (NEPH), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors IceCure Medical Daxor QT Imaging Spectral AI TELA Bio Baird Medical Investment Cytosorbents SurgePays Nephros PolyPid Carmell (NASDAQ:CTCX) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability. Do analysts prefer CTCX or ICCM? IceCure Medical has a consensus price target of $2.64, indicating a potential upside of 202.46%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts clearly believe IceCure Medical is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60 Is CTCX or ICCM more profitable? Carmell has a net margin of 0.00% compared to IceCure Medical's net margin of -317.62%. IceCure Medical's return on equity of -136.96% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% IceCure Medical -317.62%-136.96%-71.46% Which has more volatility & risk, CTCX or ICCM? Carmell has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500. Does the media prefer CTCX or ICCM? In the previous week, IceCure Medical had 12 more articles in the media than Carmell. MarketBeat recorded 12 mentions for IceCure Medical and 0 mentions for Carmell. IceCure Medical's average media sentiment score of 0.53 beat Carmell's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the news media. Company Overall Sentiment Carmell Neutral IceCure Medical Positive Do insiders & institutionals believe in CTCX or ICCM? 24.2% of Carmell shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 29.0% of Carmell shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, CTCX or ICCM? IceCure Medical has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmell$32.84K394.69-$15.44MN/AN/AIceCure Medical$3.29M18.19-$15.32M-$0.16-5.45 SummaryIceCure Medical beats Carmell on 9 of the 15 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.13M$73.92M$6.11B$10.63BDividend YieldN/AN/A5.67%4.71%P/E RatioN/A9.8685.9726.57Price / Sales394.6940.03612.03132.55Price / CashN/A18.4138.5062.09Price / Book0.5817.1212.756.53Net Income-$15.44M-$27.88M$3.31B$276.43M7 Day Performance-25.30%0.22%0.80%-0.88%1 Month Performance-77.37%1.53%6.21%3.55%1 Year Performance73.18%58.67%80.34%37.91% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$0.62-18.4%N/A+98.6%$4.13M$32.84K0.0014Gap DownICCMIceCure Medical3.0324 of 5 stars$1.000.0%$2.64+163.5%+52.8%$68.70M$3.29M-6.2560Analyst ForecastAnalyst RevisionDXRDaxor3.7545 of 5 stars$13.45-2.6%$25.00+85.9%+43.3%$66.80MN/A0.0037Analyst ForecastGap DownQTIQT ImagingN/A$2.39+2.5%N/A+284.5%$64.85M$4.00M0.00N/APositive NewsMDAISpectral AI2.9124 of 5 stars$2.38-1.7%$3.50+47.1%+78.4%$64.69M$29.58M-3.4583News CoverageAnalyst ForecastHigh Trading VolumeTELATELA Bio2.3137 of 5 stars$1.57+3.6%$4.50+186.6%-38.7%$60.02M$69.30M-1.40120News CoverageAnalyst ForecastBDMDBaird Medical InvestmentN/A$1.74+4.2%N/A-58.4%$59.67MN/A0.00N/ANews CoverageAnalyst ForecastHigh Trading VolumeCTSOCytosorbents1.9423 of 5 stars$0.95+0.6%$5.50+481.8%-12.8%$59M$35.60M-5.56220Positive NewsSURGSurgePays3.0955 of 5 stars$2.82-1.7%$9.50+236.9%+48.0%$58.64M$60.88M-1.1340News CoverageAnalyst ForecastNEPHNephros1.3162 of 5 stars$5.68+4.4%$5.50-3.2%+270.6%$57.67M$14.16M47.3330News CoveragePositive NewsAnalyst ForecastPYPDPolyPid3.0843 of 5 stars$3.33-5.9%$12.40+272.4%-9.5%$56.28MN/A-0.8780News CoveragePositive NewsAnalyst ForecastShort Interest ↑ Related Companies and Tools Related Companies ICCM Alternatives DXR Alternatives QTI Alternatives MDAI Alternatives TELA Alternatives BDMD Alternatives CTSO Alternatives SURG Alternatives NEPH Alternatives PYPD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
